Inhaled Sargramostim (Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor) for COVID-19-Associated Acute Hypoxemia: Results of the Phase 2, Randomized, Open-Label Trial (iLeukPulm)

INTRODUCTION: Granulocyte-macrophage colony-stimulating factor (GM-CSF), a protein produced in the lung, is essential for pulmonary host defense and alveolar integrity. Prior studies suggest potential benefits in several pulmonary conditions, including acute respiratory distress syndrome and viral i...

Descripción completa

Detalles Bibliográficos
Autores principales: Paine, Robert, Chasse, Robert, Halstead, E Scott, Nfonoyim, Jay, Park, David J, Byun, Timothy, Patel, Bela, Molina-Pallete, Guido, Harris, Estelle S, Garner, Fiona, Simms, Lorinda, Ahuja, Sanjeev, McManus, John L, Roychowdhury, Debasish F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Feature Article and Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363010/
https://www.ncbi.nlm.nih.gov/pubmed/36458916
http://dx.doi.org/10.1093/milmed/usac362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363010/
https://www.ncbi.nlm.nih.gov/pubmed/36458916
http://dx.doi.org/10.1093/milmed/usac362

Ejemplares similares